Skip to content

Advertisement

Chinese Medicine

Research
Open Access

Antiviral biflavonoids from Radix Wikstroemiae (Liaogewanggen)

  • Weihuan Huang1,
  • Xiaoli Zhang2, 3,
  • Yifei Wang4,
  • Wencai Ye2, 3,
  • Vincent EC Ooi1,
  • Hau Yin Chung1 and
  • Yaolan Li2, 3Email author
Chinese Medicine20105:23

https://doi.org/10.1186/1749-8546-5-23

©  Huang et al; licensee BioMed Central Ltd. 2010

Received: 11 March 2010

Accepted: 21 June 2010

Published: 21 June 2010

Abstract

Background

Radix Wikstroemiae is a common Chinese herbal medicine. The ethyl acetate fraction of the ethanolic extract of W. indica possesses potent in vitro antiviral activity against respiratory syncytial virus (RSV). This study aims to identify the antiviral components of the active fraction.

Methods

The active fraction of the Radix Wikstroemiae extract was isolated with chromatographic methods such as silica gel, Sephadex LH-20 and semi-preparative high performance liquid chromatography (HPLC) columns. The structures of the isolated compounds were determined based on spectroscopic analyses. The in vitro antiviral activity of the compounds against RSV was tested with the cytopathic effect (CPE) reduction assay and the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) method.

Results

Four biflavonoids, namely neochamaejasmin B, genkwanol B, genkwanol C and stelleranol, were isolated and characterized. Genkwanol B, genkwanol C and stelleranol, which are stereo isomers of spirobiflavonoids, showed potent anti-RSV activity whereas neochamaejasmin B did not.

Conclusion

Neochamaejasmin B, genkwanol B, genkwanol C and stelleranol were isolated from Radix Wikstroemiae and the complete absolute configurations of five chiral carbons in stelleranol were substantiated for the first time. Furthermore, the anti-RSV activity of genkwanol B, genkwanol C and stelleranol was reported for the first time.

Keywords

Respiratory Syncytial VirusAntiviral ActivityEthyl Acetate FractionChiral CarbonLight Yellow Powder

Background

The root of Wikstroemia indica (Linn.) C. A. Mey. (Thymelaeaceae) (Radix Wikstroemiae, Liaogewanggen) is a Chinese herbal medicine used to treat various inflammatory conditions [1]. W. indica tablet, an over-the-counter product made from the aqueous extract of Radix Wikstroemiae, is commercially available in China for the treatment of bronchitis, pneumonia, tonsillitis, parotitis and mastitis according to the Pharmacopoeia of China [2]. Moreover, W. indica have antifungal, anti-inflammatory, anti-cancer, antiviral and antimalarial effects [3–6]. Bioactive components of W. indica include (+)-nortrachelogenin, bis-5,5-nortrachelogenin, tricin, genkwanol A, kaempferol-3-O-beta-D-glucopyranoside, wikstrol A, wikstrol B, daphnodorin B, sikokianin B, sikokianin C, indicanone, lirioresinol B and daphnoretin [3–8]. In our previous study, the ethyl acetate fraction of the ethanolic extract of Radix Wikstroemiae possessed in vitro antiviral activity against RSV with IC50 value of < 3.9 μg/ml and selective index (SI) of > 64.1. Besides, daphnoretin (a dicoumarin compound) is one of the active components in the fraction, which mainly exerts its antiviral effects on the later phase of the viral replication cycle [9]. This article reports the isolation, structural characterization and in vitro antiviral tests of four biflavonoids, namely, (I) neochamaejasmin B, (II) genkwanol B, (III) genkwanol C and (IV) stelleranol from the ethyl acetate fraction of the ethanolic extract of Radix Wikstroemiae.

Methods

Plant material

Radix Wikstroemiae was purchased from a Chinese medicine pharmacy in Guangzhou, China. The authentication process was carried out by Zhengqiu Mai (Chinese Medicinal Material Company, Guangzhou, China) according to standard protocols [2]. A voucher specimen was deposited in the Institute of Traditional Chinese Medicine and Natural Products, College of Pharmacy, Jinan University (Guangzhou, China) with an accession number of 06111205.

General experimental procedures

Optical rotations were determined on a Jasco P-1020 digital polarimeter (JASCO Corporation, Japan). The spectra of electrospray ionization-mass spectrometry (ESI-MS) were recorded on a Finnigan LCQ Advantage Max ion trap mass spectrometer (Thermo Finnigan, USA). The spectra of high resolution-electrospray ionization-mass spectrometry (HR-ESI-MS) were acquired with a Micromass Q-TOF mass spectrometer (Waters Corporation, USA). The spectra of nuclear magnetic resonance spectrometry (NMR) including proton magnetic resonance spectrometry (1H-NMR) and carbon magnetic resonance spectrometry (13C-NMR) were obtained on a Bruker spectrometer (Bruker Corporation, Switzerland) operating at 500 MHz for 1H-MNR and 125 MHz for 13C-NMR respectively. The isolation process was conducted on silica gel (200-300 meshes, Qingdao Marine Chemical, China), Sephadex LH-20 (25-100 μm, Fluka, Switzerland) and semi-preparative HPLC. Semi-preparative HPLC was performed on an Eclipse XDB-C18 column (9.4 mm ID × 25 cm) (Agilent Technologies, USA). Thin layer chromatography (TLC) was carried out on silica gel GF254 plates (0.2 mm thickness, 10 × 20 cm, Qingdao Marine Chemical, China) with FeCl3-EtOH reagent and ultraviolet (UV) illumination as chromogenic methods.

Extraction and isolation

The dried and cut Radix Wikstroemiae (10.0 kg) was soaked in 95% ethanol at room temperature for three times (15 days each time). The ethanol solutions were then combined and concentrated in vacuo to yield a dark brown crude extract (1.0 kg). The ethanol extract was suspended in distilled water and partitioned with petroleum ether, ethyl acetate and n-butanol successively. After evaporation under reduced pressure, the petroleum ether fraction (5.0 g), ethyl acetate fraction (580.0 g) and butanol fraction (400.0 g) were obtained respectively.

The ethyl acetate fraction (550.0 g) was chromatographed on a silica gel column eluted with a solvent system of petroleum ether/ethyl acetate in gradient to obtain 28 subfractions based on the TLC analysis. The subfractions Fr-12 and Fr-23, which yielded positive reaction with FeCl3-EtOH reagent, were further isolated.

Fr-12 (12.6 g) was isolated with repeated silica gel columns eluted with gradient solvent systems of chloroform/acetone and chloroform/methanol, respectively, followed by Sephadex LH-20 column eluted with chloroform/methanol (3/7) to yield compound I (20.0 mg).

Fr-23 (12.6 g) was subjected to repeated silica gel columns eluted with gradient solvent system of chloroform/methanol, followed by semi-preparative HPLC on an Eclipse XDB-C18 column (Agilent Technologies, USA) with a gradient solvent system of 0.1% TFA (A) and methanol (B) to yield compounds II (40.7 mg), III (60.3 mg) and IV (20.7 mg).

Identification

Compound I (neochamaejasmin B), an amorphous brown powder, was positive to FeCl3-EtOH reagent. [α]D = 200° (c 0.1, MeOH). ESI-MS: m/z 541 [M-H] - .1 H-NMR (500 MHz, CD3OD) δ: 7.17 (2H, d, J = 8.4 Hz, H-2''', H-6'''), 6.94 (2H, d, J = 8.4 Hz, H-2', H-6'), 6.81 (2H, d, J = 8.4 Hz, H-3''', H-5'''), 6.67 (2H, d, J = 8.4 Hz, H-3', H-5'), 6.00 (1H, d, J = 1.8 Hz, H-8''), 5.89 (1H, d, J = 1.8 Hz, H-8), 5.80 (1H, d, J = 1.8 Hz, H-6''), 5.78 (1H, d, J = 1.8 Hz, H-6), 5.57 (1H, d, J = 4.6 Hz, H-2), 5.16 (1H, d, J = 8.8 Hz, H-2''), 3.29 (1H, dd, J = 3.2, 8.8 Hz, H-3''), 3.16 (1H, brs, H-3). 13C-NMR (125 MHz, CD3OD) δ: 198.6 (C-4''), 196.3 (C-4), 168.3 (C-7''), 168.1 (C-7), 165.1 (C-8''a), 165.4 (C-5''), 165.2 (C-5), 163.4 (C-8a), 159.0 (C-4'''), 158.6 (C-4'), 130.3 (C-2''', 6'''), 129.1 (C-1'''), 128.8 (C-1'), 128.5 (C-2', 6'), 116.4 (C-3''', 5'''), 116.2 (C- 3', 5'), 105.1 (C-4''a) ,103.9 (C-4a), 97.3 (C-6''), 97.1 (C-6), 96.4 (C-8''), 96.0 (C-8), 83.3 (C-2''), 81.5 (C-2), 50.8 (C-3''), 49.7 (C-3).

Compound II (genkwanol B), a light yellow powder, was positive to FeCl3-EtOH reagent. [α]D = -160° (c 0.1, MeOH). HR-ESI-MS m/z: 557.10805 [M-H] - .1 H-NMR (500 MHz, DMSO-d 6 ) δ: 7.09 (2H, d, J = 8.5 Hz, H-2''', H-6'''), 6.73 (2H, d, J = 8.5 Hz, H-3''', H-5'''), 6.58 (2H, d, J = 8.5 Hz, H-2', H-6'), 6.51 (2H, d, J = 8.5 Hz, H-3', H-5'), 6.11 (1H, d, J = 2.0 Hz, H-8''), 6.04 (1H, d, J = 2.0 Hz, H-6''), 5.71 (1H, s, H-6), 4.56 (1H, d, J = 8.2 Hz, H-2), 3.55 (1H, m, H-3), 2.59 (1H, dd, J = 8.9, 16.7 Hz, H-4), 2.05 (1H, dd, J = 5.0, 16.7 Hz, H-4). 13C-NMR (125 MHz, DMSO-d 6 ) δ: 190.4 (C-4''), 186.3 (C-5), 168.6 (C-7), 167.7 (C-7''), 163.3 (C-5''), 160.1 (C-8''a), 158.1 (C-4'''), 157.9(C-8a), 156.7 (C-4'), 129.8 (C-2''', 6'''), 127.9 (C-1'), 127.3 (C-2', 6'), 122.0 (C-1'''), 114.6 (C-3''', 5'''), 114.4 (C-3', 5'), 109.2 (C-4a) ,100.4 (C-6), 99.8 (C-4''a), 97.0 (C-6''), 96.1 (C-8''), 89.9 (C-2''), 85.0 (C-8), 82.0 (C-2), 79.8 (C-3''), 66.4 (C-3), 27.0 (C-4).

Compound III (genkwanol C), a light yellow powder, was positive to FeCl3-EtOH reagent. [α]D = +15° (c 0.1, MeOH). HR-ESI-MS m/z: 557.10863 [M-H] -. 1H-NMR (500 MHz, DMSO-d 6 ) δ: 7.07 (2H, d, J = 8.5 Hz, H-2''', H-6'''), 6.96 (2H, d, J = 8.5 Hz, H-2', H-6'), 6.74 (2H, d, J = 8.5 Hz, H-3''', H-5'''), 6.51 (2H, d, J = 8.5 Hz, H-3', H-5'), 6.00 (1H, d, J = 2.0 Hz, H-8''), 5.93 (1H, d, J = 2.0 Hz, H-6''), 5.72 (1H, s, H-6), 4.61 (1H, d, J = 6.5 Hz, H-2), 3.77 (1H, m, H-3), 3.16 (1H, d, J = 6.5 Hz, H-4), 2.21 (1H, d, J = 4.0 Hz, H-4). 13C-NMR (125 MHz, DMSO-d 6 ) δ: 190.3 (C-4''), 186.3 (C-5), 168.5 (C-7), 167.3 (C-7''), 162.6 (C-5''), 160.2 (C-8''a), 158.1 (C-8a), 157.3 (C-4'''), 156.7 (C-4'), 129.6 (C-2''', 6'''), 127.8 (C-1'), 127.4 (C-2', 6'), 121.9 (C-1'''), 114.6 (C-3''', 5'''), 114.5 (C-3', 5'), 109.5 (C-4a) ,100.48 (C-6), 99.2 (C-4''a), 97.8 (C-6''), 95.7 (C-8''), 90.4 (C-2''), 84.6 (C-8), 81.8 (C-2), 79.9(C-3''), 65.0(C-3), 25.5 (C-4).

Compound IV (stelleranol), a light yellow powder, was positive to FeCl3-EtOH reagent. [α]D = -102° (c 0.1, MeOH). HR-ESI-MS m/z: 557.10913 [M-H] -. CD (c 6.25×10-5, MeOH) Δε (nm): 0 (394), -6.8 (342), 0 (327), +31.8 (305), 0 (279), -18.6 (259), -7.5 (242), - 21.2 (219), 0 (206). 1H-NMR (500 MHz, acetone-d 6 ) δ: 7.22 (2H, d, J = 8.5 Hz, H-2''', H-6'''), 6.83 (2H, d, J = 8.5 Hz, H-3''', H-5'''), 6.71 (2H, d, J = 8.5 Hz, H-2', H-6'), 6.62 (2H, d, J = 8.5 Hz, H-3', H-5'), 6.16 (1H, d, J = 2.0 Hz, H-8''), 6.14 (1H, d, J = 2.0 Hz, H-6''), 6.09 (1H, s, H-2''), 5.68 (1H, s, H-6), 4.96 (1H, s, H-2), 4.18 (1H, brs, H-3), 2.65 (1H, d, J = 17.5 Hz, H-4), 2.49 (1H, dd, J = 3.8, 17.3 Hz, H-4). 13C-NMR (125 MHz, acetone-d 6 ) δ: 193.1 (C-4''), 188.7 (C-5), 170.4 (C-7), 169.6 (C-7''), 166.1 (C-8''a), 163.1 (C-5''), 160.3 (C-8a), 159.9 (C-4'''), 158.6 (C-4'), 131.7 (C-2''', 6'''), 130.4 (C-1'), 129.2 (C-2', 6'), 124.7 (C-1'''), 116.7 (C-3''', 5'''), 116.5 (C-3', 5'), 111.1 (C-4a) ,102.9 (C-6), 102.0 (C-4''a), 99.0 (C-6''), 98.4 (C-8''), 92.2 (C-2''), 87.5 (C-8), 82.3 (C-2), 82.1 (C-3''), 66.5 (C-3), 28.6 (C-4).

Cell and virus

Human larynx epidermoid carcinoma cell line (HEp-2, CCL-23) and RSV (long strain, VR-26) were purchased from the American Type Culture Collection (ATCC, USA). The cells were grown in Eagle's minimum essential medium (EMEM) (Gibco, USA) supplemented with 10% fetal bovine serum (FBS) (Gibco, USA), 25 μg/ml gentamicin (Sigma, USA) and 200 mM L-glutamine (Sigma, USA) (growth medium). Virus-infected cells were maintained in EMEM with 1% FBS, 25 μg/ml gentamicin and 200 mM L-glutamine (maintenance medium). All the cells were cultured at 37°C in a humidified atmosphere supplied with 5% CO2. Virus titers were determined by the 50% tissue culture infective dose (TCID50) method.

Cytotoxicity assay

Cell viability was tested by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) method as described in previous study [10]. Briefly, 100 μl of two-fold diluted samples were added to a 96-well plate containing confluent cell monolayer in triplicates while the dilution medium without the sample was the control. After 72 hours of incubation, 12 μl of the MTT solution (5 mg/ml in phosphate buffered saline) was added to each well. The trays were further incubated for four hours for the formation of blue formazan. After the supernatant was removed, the blue formazan was solubilized in 100 μl DMSO and the optical density (OD) was measured at 570 nm with a microplate reader.

Antiviral assay

CPE reduction assay was adopted for screening the in vitro antiviral activity as described in the previous study [10]. Briefly, 0.1 ml of 100 TCID50 virus suspension and serial two-fold dilutions of the tested samples were added simultaneously to confluent cell monolayers in a 96-well plate. Virus suspension and maintenance medium without samples were added as the virus control and cell control, respectively. The plates were incubated at 37°C in a humidified CO2 atmosphere for 3-5 days. The virus-induced CPE was scored against the virus control under a light microscope. Ribavirin (Sigma, USA) was used as positive control in this experiment.

Results

Chemical structures of the isolated compounds

Compound IV was isolated as a light yellow powder. Positive FeCl3 reaction showed the presence of phenolic hydroxyl groups. The molecular formula of compound IV was determined to be C30H22O11 by HR-ESI-MS (m/z 557.10931 [M-H] -, calcd. for C30H21O11 m/z 557.10893). Proton and carbon signals were assigned by a combination of 1D- and 2D-NMR spectra. The 1H-NMR spectrum of compound IV showed signals assignable to a pair of 1,4-disubstituted aromatic rings [δ 7.22 (2H, d, J = 8.5 Hz), 6.71 (2H, d, J = 8.5 Hz), 6.83 (2H, d, J = 8.5 Hz), and 6.62 (2H, d, J = 8.5 Hz)], one 1,2,4,6-tetra substituted aromatic ring [δ 6.16 (1H, d, J = 2.0 Hz), and 6.14 (1H, d, J = 2.0 Hz)] and one 3-hydroxy-2,5,6-trisubstituented dihydropyran [δ 4.96 (1H, s), 4.18 (1H, brs), 2.65 (1H, d, J = 17.5 Hz), 2.49 (1H, dd, J = 3.8, 17.3 Hz)]. Moreover, two singlet signals were observed at δ 6.09 (1H, s) and 5.68 (1H, s). In the 13C-NMR spectrum of compound IV, two carbonyl carbons (δ 193.1 and 188.7) and two quaternary carbons with attachment of oxygen atoms (δ 87.5 and 82.1) were observed in addition to the signals described above. The 1H-NMR and 13C-NMR data of compound IV were consistent with those of stelleranol [11, 12]. There were five chiral carbons including C-2, C-3, C-8, C-2'', and C-3'' in the structure of stelleranol (Figure 1). Among them, the absolute configurations at both C-2 and C-3 were determined to be R according to comparison of the NMR data of stelleranol with the published data of (-)-epicatechin [11, 12]. The absolute configurations of another three carbons, namely C-8, C-2'' and C-3'', were determined by comparison of the CD spectrum of compound IV with those of genkwanol B (2) and genkwanol C (3) [13]. The CD spectrum of compound IV (Figure 2) was similar to that of genkwanol C, and opposite to that of genkwanol B. Therefore, the absolute configurations at C-2, C-3, C-8, C-2'' and C-3'' positions of stelleranol were fully substantiated to be R, R, R, R and S.
Figure 1
Figure 1

The chemical structures of biflavonoids I-IV.

Figure 2
Figure 2

The CD spectra of biflavonoid IV in MeOH.

We also identified compounds I-III to be neochamaejasmin B (I), genkwanol B (II), genkwanol C (III) by comparing their spectra with the published data [13–15]. Compound I was a biflavonone whereas compounds II-IV were stereo isomers of spirobiflavonoids (Figure 1).

Antiviral activity of the isolated compounds

The in vitro antiviral activity of compounds I-IV against RSV was tested with CPE reduction assay and the MTT method. The SI value calculated from the ratio of CC50 to IC50 was used as an important parameter to evaluate the in vitro antiviral activity of the compounds. Compounds II, III and IV showed similar in vitro antiviral activity against RSV with IC50 values of 9.6, 6.6, 10.2 μM and SI values of 11.0, 21.9, 15.8 respectively whereas compound I did not show anti-RSV effect in its maximal non-cytotoxic concentration (MNCC), the highest concentration tested in the CPE reduction assay (Table 1).
Table 1

In vitro anti-RSV activity of compounds I-IV (n = 3)

Compound

CC50(μM) a

IC50(μM) b

SI

I

29.9 (3.2)

-

-

II

106.1 (5.9)

9.6 (0.7)

11.0

III

145.3 (3.1)

6.6 (1.1)

21.9

IV

161.5 (5.7)

10.2 (0.8)

15.8

Ribavirin

256.1 (3.2)

11.9 (0.2)

21.6

a CC50 is the concentration of sample with half maximal inhibition on the growth and survival of HEp-2 cells; data are expressed as mean (SD).

b IC50 is the concentration that reduced 50% of CPE in respect to virus control; data are expressed as mean (SD).

-: The sample did not show anti-RSV effect at its NMCC.

Discussion

Quite a few biflavonoids possess antiviral activities against a number of viruses such as RSV [4, 16–20]. Biflavonoids isolated from Radix Wikstroemiae, e.g. (+)-nortrachelogenin, genkwanol A, wikstrol B and daphnodorin B, are moderately active against HIV-1 in vitro [4]. However, the anti-RSV activity of biflavonoids from W. indica has not been discussed before. Three spirobiflavonoids II, III and IV possess similar potent anti-RSV activity to the positive controlled drug ribavirin. In addition, stelleranol is a spirobiflavonoid consisted of five chiral carbons. The absolute configurations of the five chiral carbons in stelleranol are completely substantiated in this study, and the CD spectrum of stelleranol has been given for the first time.

Conclusion

Neochamaejasmin B, genkwanol B, genkwanol C and stelleranol were isolated from Radix Wikstroemiae and the complete absolute configurations of five chiral carbons in stelleranol were substantiated for the first time. Furthermore, the anti-RSV activity of genkwanol B, genkwanol C and stelleranol was reported for the first time.

Abbreviations

CPE: 

cytopathic effect

ESI-MS: 

electrospray ionization-mass spectrometry

HPLC: 

high performance liquid chromatography

HR-ESI-MS: 

high resolution-electrospray ionization-mass spectrometry

MTT: 

3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide

NMR: 

nuclear magnetic resonance spectrometry

1H-MNR: 

proton magnetic resonance spectrometry

13C-NMR: 

carbon magnetic resonance spectrometry

RSV: 

respiratory syncytial virus

SI: 

selective index

TLC: 

thin layer chromatography

UV: 

ultraviolet

HIV: 

human immunodeficiency virus.

Declarations

Acknowledgements

This work was partially supported by the Natural Science Foundation of Guangdong Province (06025165), the Ministry of Education Key Project, China (106155), the Team Project of Natural Science Foundation of Guangdong Province (8351063201000003), and the Joint Funds of National Science Foundation of China (U0632010).

Authors’ Affiliations

(1)
Department of Biology, The Chinese University of Hong Kong, China
(2)
Institute of Traditional Chinese Medicine and Natural Products, Jinan University, Guangzhou, China
(3)
Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine and New Drug Research, Jinan University, Guangzhou, China
(4)
Biomedicine Research and Development Center, Jinan University, Guangzhou, China

References

  1. A group of editors for Chinese Materia Medica: Liaogewang. Chinese Materia Medica. 1999, Shanghai: Shanghai Science and Technology Press, 423-427.Google Scholar
  2. The Pharmacopoeia Committee of the Ministry of Public Health, China: Liaogewang tablet. Pharmacopoeia of the People's Republic of China 1977. 1978, Beijing: People's Medical Publishing House, 16-17.Google Scholar
  3. Lee KH, Tagahara K, Suzuki H, Wu RY, Haruna M, Hall IH, Huang HC, Ito K, Iida T, Lai JS: Antitumor agents. 49. Tricin, kaempferol-3-O-beta-D-glucopyranoside and (+)-nortrachelogenin, antileukemic principles from Wikstroemia indica. J Nat Prod. 1981, 44: 530-535. 10.1021/np50017a003.View ArticlePubMedGoogle Scholar
  4. Hu K, Kobayashi H, Dong A, Iwasaki S, Yao X: Antifungal, antimitotic and anti-HIV-1 agents from the roots of Wikstroemia indica. Planta Med. 2000, 66: 564-567. 10.1055/s-2000-8601.View ArticlePubMedGoogle Scholar
  5. Nunome S, Ishiyama A, Kobayashi M, Otoguro K, Kiyohara H, Yamada H, Omura S:In vitro antimalarial activity of biflavonoids from Wikstroemia indica. Planta Med. 2004, 70: 76-78. 10.1055/s-2004-815462.View ArticlePubMedGoogle Scholar
  6. Wang LY, Unehara T, Kitanaka S: Anti-inflammatory activity of new guaiane type sesquiterpene from Wikstroemia indica. Chem Pharm Bull (Tokyo). 2005, 53: 137-139. 10.1248/cpb.53.137.View ArticleGoogle Scholar
  7. Kato A, Hashimoto Y, Kidokoro M: (+)-Nortrachelogenin, a new pharmacologically active lignan from Wikstroemia indica. J Nat Prod. 1979, 42: 159-162. 10.1021/np50002a004.View ArticlePubMedGoogle Scholar
  8. Wang LY, Unehara N, Kitanaka S: Lignans from the roots of Wikstroemia indica and their DPPH radical scavenging and nitric oxide inhibitory activities. Chem Pharm Bull (Tokyo). 2005, 53: 1348-1351. 10.1248/cpb.53.1348.View ArticleGoogle Scholar
  9. Ho WS, Xue JY, Sun SSM, Ooi VEC, Li YL: Antiviral activity of daphnoretin isolated from Wikstroemia indica. Phytother Res. 2010, 24: 657-661.PubMedGoogle Scholar
  10. Li Y, But PPH, Ooi VEC: Antiviral activity and mode of action of caffeoylquinic acids from Schefflera heptaphylla (L.) Fordin. Antiviral Res. 2005, 68: 1-9. 10.1016/j.antiviral.2005.06.004.View ArticlePubMedGoogle Scholar
  11. Feng BM, Pei YH, Hua HM: A new biflavonoid from Stellera chamaejasme L. Chin Chem Lett. 2004, 15: 61-62.Google Scholar
  12. Feng BM, Gong XJ, Shi LY, Jiang G, Pei YH, Huang YQ: Studies on phenolic compounds from Stellera chamaejasme. Zhongguo Zhong Yao Za Zhi. 2008, 33: 403-405.PubMedGoogle Scholar
  13. Baba K, Taniguchi M, Kozawa M: A third spirobiflavonoid genkwanol C from Daphne genkwa. Phytochemistry. 1993, 33: 913-916. 10.1016/0031-9422(93)85303-9.View ArticleGoogle Scholar
  14. Baba K, Taniguchi M, Kozawa M: A spirobiflavonoid genkwanol B from Dapnhe genkwa. Phytochemistry. 1992, 31: 975-980.View ArticleGoogle Scholar
  15. Niwa M, Tatmatsu H, Liu GQ: Isolation and structure of two C-3/C-3''-biflavonids neochamaejasmenin A and neochamaejasmenin B. Chem Lett. 1984, 148: 539-542. 10.1246/cl.1984.539.View ArticleGoogle Scholar
  16. Lin YM, Anderson H, Flavin MT, Pai YHS: In vitro anti-HIV activity of biflavanoids isolated from Rhus succedanea and Garcinia multiflora. J Nat Prod. 1997, 60: 884-888. 10.1021/np9700275.View ArticlePubMedGoogle Scholar
  17. Miki K, Nagai T, Suzuki K, Tsujimura R, Koyama K, Kinoshita K, Furuhata K, Yamada H, Takahashi K: Anti-influenza virus activity of biflavonoids. Bioorg Med Chem Lett. 2007, 17: 772-775. 10.1016/j.bmcl.2006.10.075.View ArticlePubMedGoogle Scholar
  18. Sanchez I, Gomez-Garibay F, Taboada J, Ruiz BH: Antiviral effect of flavonoids on the dengue virus. Phytother Res. 2000, 14: 89-92. 10.1002/(SICI)1099-1573(200003)14:2<89::AID-PTR569>3.0.CO;2-C.View ArticlePubMedGoogle Scholar
  19. Lin YM, Flavin MT, Schure R, Chen FC, Sidwell R, Barnard DI, Huffman JH, Kern ER: Antiviral activities of biflavonoids. Planta Med. 1999, 65: 120-125. 10.1055/s-1999-13971.View ArticlePubMedGoogle Scholar
  20. Ma SC, But PPH, Ooi VEC, He YH, Lee SHS, Lee SF, Lin RC: Antiviral amentoflavone from Selaginella sinensis. Biol Pharm Bull. 2001, 24: 311-312. 10.1248/bpb.24.311.View ArticlePubMedGoogle Scholar

Copyright

© Huang et al; licensee BioMed Central Ltd. 2010

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement

Chinese Medicine

ISSN: 1749-8546

Contact us